Company intelligence / Profile preview

OCD.app

Ownership: Private
Development stage: Commercial

Overview

OCD.app is a digital mental health platform that delivers evidence-based cognitive-behavioral interventions for obsessive-compulsive disorder and related conditions. Supported by 16 published studies—including 10 randomized controlled trials—the app has demonstrated clinically significant improvements in symptoms for 15.9% to 24% of users after 2–5 weeks of use. The strongest effects are seen in users with moderate to severe symptoms. The app is endorsed by major organizations and used by over 150,000 people worldwide.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapyDevice (mobile application)Cognitive behavioral therapy-based digital intervention
Industry: Digital Health Medical Devices

Partnerships

Endorsed or featured by International OCD Foundation and OneMind Psyberguide.

Beyond the preview

Go deeper on OCD.app.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OCD.app.

Explore the full profile